Vascular-Preserving Hepatic Resection Technologies: Advances, Clinical Implications, and Future Directions

Abstract

Vascular-preserving hepatic resection technologies represent a significant paradigm shift in hepatobiliary surgery, offering the potential for optimal oncologic outcomes while minimizing perioperative morbidity and preserving critical vascular structures. This review examines the latest advancements, underlying mechanisms, clinical applications, and guideline-based recommendations for vascular-preserving hepatic resections. Emphasis is given to intraoperative strategies, device innovations, and their impact on surgical safety and patient prognosis, with a focus on providing evidence-based insights for practicing surgeons and hepatology specialists.

Introduction

Hepatic resection remains the cornerstone therapy for primary and secondary liver malignancies, but its complexity is amplified by the intricate vascular anatomy of the liver. Traditionally, extensive resections risked significant loss of functional parenchyma and vascular compromise, contributing to increased morbidity and diminished postoperative liver function. Recent technological advancements have enabled surgeons to perform precise, vascular-sparing resections, enhancing safety and expanding indications for surgery. The following review provides a comprehensive appraisal of these technologies, their scientific basis, and clinical implications, with guidance drawn from contemporary literature and expert consensus.

Epidemiology / Disease Burden

Primary liver malignancies, notably hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma, as well as metastatic colorectal cancer to the liver, are leading indications for hepatic resection. Globally, liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer-related mortality. The incidence of resectable hepatic neoplasms continues to rise, paralleling advances in imaging and systemic therapy. Despite improvements in perioperative management, post-hepatectomy liver failure and vascular complications remain significant contributors to morbidity and mortality, underscoring the need for vascular-preserving techniques.

Pathophysiology

Liver resection disrupts the hepatic vascular architecture, potentially leading to ischemic injury, congestion, and impaired regeneration. The liver’s dual blood supply portal vein and hepatic artery necessitates careful preservation of inflow and outflow during parenchymal transection. Conventional resection methods may inadvertently sacrifice vascular branches, resulting in greater loss of viable tissue and increased risk of postoperative liver dysfunction. Vascular-preserving technologies aim to mitigate these effects by enabling precise identification and selective ligation or preservation of hepatic vessels, thereby maintaining optimal perfusion and reducing ischemia-reperfusion injury.

Risk Factors

Risk factors for perioperative vascular compromise include tumor proximity to major hepatic veins or portal structures, underlying cirrhosis, steatosis, prior locoregional therapy, and anatomical variations. Patients with limited future liver remnant (FLR), chronic liver diseases, and those undergoing repeat resections are particularly vulnerable to vascular injury. Accurate preoperative assessment and intraoperative navigation are essential to stratify risk and guide the use of vascular-preserving technologies in high-risk cohorts.

Clinical Features

The clinical presentation of patients requiring hepatic resection varies, but common features include right upper quadrant pain, jaundice, weight loss, and incidental radiographic findings. Vascular involvement may manifest as biliary obstruction, portal hypertension, or hepatic venous outflow obstruction. Careful preoperative mapping of vascular anatomy using contrast-enhanced imaging informs the surgical approach and the need for vascular-preserving interventions.

Diagnosis

Diagnosis and surgical planning rely heavily on multiphasic contrast-enhanced CT and MRI, with three-dimensional (3D) reconstruction increasingly employed to delineate vascular anatomy. Intraoperative ultrasonography and fluorescence imaging (e.g., indocyanine green) provide real-time assessment of vascular flow and tumor margins. These diagnostic modalities facilitate the identification of critical vessels and support the intraoperative application of vessel-preserving strategies.

Treatment & Management

The primary goal of hepatic resection is complete tumor removal with negative margins while maximizing preservation of functional liver tissue and vascular integrity. Traditional anatomic resections (segmentectomy, lobectomy) often entail ligation of major vascular structures. Vascular-preserving approaches, such as parenchymal-sparing non-anatomic resections and selective vascular isolation, have gained prominence. Advanced energy devices (e.g., ultrasonic dissectors, bipolar sealing systems) and stapling technology allow for meticulous dissection and hemostasis with minimal collateral tissue damage. Preoperative portal vein embolization (PVE) and associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) have also contributed to improved vascular management in complex cases.

Recent Advances / Emerging Therapies

Recent advances include the integration of robotic and laparoscopic platforms, which enhance dexterity and visualization for vascular-preserving resections. Indocyanine green fluorescence imaging facilitates precise parenchymal transection along vascular boundaries. The use of 3D-printed patient-specific models aids in preoperative planning and intraoperative navigation. Radiofrequency-assisted and microwave-assisted resection devices enable coagulative necrosis around vessels, allowing safe dissection near major structures. Additionally, ongoing development of intraoperative imaging software and augmented reality tools is expected to further improve vascular preservation and surgical accuracy. Recent studies have demonstrated that these technologies reduce intraoperative blood loss, operative time, and hospital stay, while maintaining oncologic efficacy.

Guideline Recommendations

Current guidelines from the American Association for the Study of Liver Diseases (AASLD), European Association for the Study of the Liver (EASL), and International Hepato-Pancreato-Biliary Association endorse the use of vascular-preserving techniques where feasible, particularly in patients with limited FLR or preexisting liver disease. Routine preoperative assessment of vascular anatomy and liver function is recommended. The choice of resection technique should be individualized, taking into account tumor location, vascular involvement, and patient-specific risk factors. Multidisciplinary collaboration is emphasized to optimize perioperative outcomes and minimize complications.

Conclusion

Vascular-preserving hepatic resection technologies represent a transformative advancement in liver surgery, enabling safer and more effective management of hepatic malignancies. By minimizing vascular compromise and maximizing parenchymal preservation, these techniques improve postoperative outcomes and expand the pool of surgical candidates. Ongoing research and technological innovation will likely further refine these approaches, with the ultimate goal of enhancing patient survival and quality of life. Surgeons and hepatology specialists should remain abreast of emerging evidence and incorporate guideline-based, individualized strategies into clinical practice.